Brinker Capital Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.56M | Sell |
8,497
-2,943
| -26% | -$542K | 0.01% | 884 |
|
|
2025
Q4 | $2.01M | Buy |
11,440
+6,612
| +137% | +$1.08M | 0.01% | 844 |
|
|
2025
Q3 | $676K | Sell |
4,828
-3,759
| -44% | -$508K | 0.01% | 1415 |
|
|
2025
Q2 | $1.08M | Buy |
8,587
+1,121
| +15% | +$140K | 0.01% | 1157 |
|
|
2025
Q1 | $1.02M | Buy |
7,466
+620
| +9% | +$88.6K | 0.01% | 1073 |
|
|
2024
Q4 | $1.05M | Buy |
6,846
+754
| +12% | +$127K | 0.01% | 1029 |
|
|
2024
Q3 | $1.18M | Sell |
6,092
-1,237
| -17% | -$259K | 0.01% | 957 |
|
|
2024
Q2 | $1.7M | Buy |
7,329
+140
| +2% | +$30.4K | 0.02% | 726 |
|
|
2024
Q1 | $1.55M | Sell |
7,189
-1,326
| -16% | -$311K | 0.02% | 781 |
|
|
2023
Q4 | $2.2M | Sell |
8,515
-954
| -10% | -$234K | 0.03% | 584 |
|
|
2023
Q3 | $2.43M | Buy |
9,469
+316
| +3% | +$84.5K | 0.03% | 528 |
|
|
2023
Q2 | $10.6M | Buy |
9,153
+42
| +0.5% | +$12.5K | 0.11% | 172 |
|
|
2023
Q1 | $2.53M | Buy |
9,111
+1,136
| +14% | +$314K | 0.03% | 501 |
|
|
2022
Q4 | $2.21M | Sell |
7,975
-3,217
| -29% | -$909K | 0.04% | 437 |
|
|
2022
Q3 | $2.99M | Buy |
11,192
+777
| +7% | +$165K | 0.06% | 305 |
|
|
2022
Q2 | $2.12M | Buy |
10,415
+3,205
| +44% | +$655K | 0.04% | 450 |
|
|
2022
Q1 | $1.52M | Sell |
7,210
-2,497
| -26% | -$543K | 0.02% | 640 |
|
|
2021
Q4 | $2.33M | Buy |
9,707
+827
| +9% | +$213K | 0.03% | 512 |
|
|
2021
Q3 | $3.08M | Hold |
8,880
| – | – | 0.05% | 407 |
|
|
2021
Q2 | $3.08M | Buy |
8,880
+409
| +5% | +$124K | 0.04% | 462 |
|
|
2021
Q1 | $2.37M | Sell |
8,471
-7,231
| -46% | -$1.95M | 0.04% | 461 |
|
|
2020
Q4 | $3.85M | Buy |
15,702
+8,017
| +104% | +$2.07M | 0.06% | 393 |
|
|
2020
Q3 | $2.18M | Buy |
+7,685
| New | +$2.14M | 0.04% | 444 |
|
|
2020
Q1 | – | Sell |
-195
| Closed | -$58K | – | 348 |
|
|
2019
Q4 | $58K | Buy |
195
+4
| +2% | +$1.11K | ﹤0.01% | 411 |
|
|
2019
Q3 | $44K | Sell |
191
-469
| -71% | -$109K | ﹤0.01% | 440 |
|
|
2019
Q2 | $154K | Buy |
660
+432
| +189% | +$99.8K | ﹤0.01% | 422 |
|
|
2019
Q1 | $54K | Buy |
228
+214
| +1,529% | +$67.4K | ﹤0.01% | 464 |
|
|
2018
Q4 | $4K | Hold |
14
| – | – | ﹤0.01% | 562 |
|
|
2018
Q3 | $5K | Hold |
14
| – | – | ﹤0.01% | 522 |
|
|
2018
Q2 | $4K | Buy |
+14
| New | +$3.94K | ﹤0.01% | 543 |
|
|
2017
Q3 | – | Sell |
-4
| Closed | -$1K | – | 579 |
|
|
2017
Q2 | $1K | Buy |
+4
| New | +$1.06K | ﹤0.01% | 467 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | – | – | 494 |
|
|
2016
Q3 | $0 | Sell |
1
-3,345
| -100% | -$991K | ﹤0.01% | 499 |
|
|
2016
Q2 | $809K | Buy |
3,346
+1,306
| +64% | +$344K | 0.03% | 192 |
|
|
2016
Q1 | $531K | Buy |
2,040
+96
| +5% | +$25.4K | 0.02% | 210 |
|
|
2015
Q4 | $596K | Buy |
1,944
+68
| +4% | +$19.5K | 0.03% | 214 |
|
|
2015
Q3 | $547K | Buy |
+1,876
| New | +$620K | 0.02% | 219 |
|
Other funds holding BIIB
VCM
VPM
Brinker Capital Investments's BIIB Position: Q1 2026 in Review
Brinker Capital Investments reduced its Biogen (BIIB) stake by 26% in Q1 2026, selling an estimated $542K and leaving 8,497 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #884.
Brinker Capital Investments first reported a position in BIIB in Q3 2015 and has held it in 36 quarters since. The position peaked at $10.6M in Q2 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Brinker Capital Investments held 8,497 shares of Biogen worth $1.56M as of Q1 2026.
- Brinker Capital Investments sold 2,943 Biogen shares in Q1 2026, an estimated $542K.
- Biogen made up 0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #884 holding.
- Brinker Capital Investments first reported a position in Biogen in Q3 2015 and has held it in 36 quarters since.
- Brinker Capital Investments's Biogen position peaked at $10.6M in Q2 2023.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.